BCLS II Equity Opportunities GP, LLC - Jan 11, 2024 Form 3 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director, 10%+ Owner
Signature
BCLS II EQUITY OPPORTUNITIES GP, LLC, By: Bain Capital Life Sciences Investors, LLC, its ultimate manager, By: /s/ Adam Koppel, Title: Partner
Stock symbol
SLDB
Transactions as of
Jan 11, 2024
Transactions value $
$0
Form type
3
Date filed
1/19/2024, 07:23 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLDB Common Stock 904K Jan 11, 2024 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 904,160 shares of Common Stock purchased by BCLS II Equity Opportunities, LP ("BCLS II Equity") directly from the Issuer in a private placement that closed on January 11, 2024.
F2 BCLS II Equity Opportunities GP, LLC ("BCLS II Equity GP") is the general partner of BCLS II Equity. As a result, BCLS II Equity GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Equity. BCLS II Equity GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.